Benefits and strengths of the disproportionality analysis for identification of adverse drug reactions in a pharmacovigilance database (Q5977801)

From MaRDI portal
Revision as of 14:13, 4 March 2024 by Daniel (talk | contribs) (‎Created claim: Wikidata QID (P12): Q35629751, #quickstatements; #temporary_batch_1709550817224)
scientific article
Language Label Description Also known as
English
Benefits and strengths of the disproportionality analysis for identification of adverse drug reactions in a pharmacovigilance database
scientific article

    Statements

    72
    0 references
    6
    0 references
    905-908
    0 references
    9 November 2011
    0 references
    0 references
    0 references
    0 references